242
Participants
Start Date
July 31, 2004
Study Completion Date
May 31, 2005
Risperidone
Oral risperidone capsules 1 and 2 mg; doses were 1 mg once daily on Days 1-2, 2 mg once daily on Days 3-4, 3 mg once daily on Days 5-7, and 1, 2, or 3 mg twice daily during Weeks 2-6
Ziprasidone
Oral ziprasidone capsules 40, 60, and 80 mg; doses were 40 mg twice daily on Days 1-2, 60 mg twice daily on Days 3-7, and 40, 60, or 80 mg twice daily during Weeks 2-6
Pfizer Investigational Site, Beijing
Pfizer Investigational Site, Beijing
Pfizer Investigational Site, Shanghai
Pfizer Investigational Site, Nanjing
Pfizer Investigational Site, Guangzhou
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY